Mono Bar
Main page content

Providers Clinical Support System - Medications for Opioid Use Disorders (PCSS-MOUD)


The Providers Clinical Support System - Medications for Opioid Use Disorders (PCSS-MOUD) is a SAMHSA funded national training, guidance, and clinical mentoring program to enhance the capacity of healthcare and counseling professionals to identify and treat opioid use disorder (OUD).

body 2

PCSS-MOUD trains health professionals to provide effective, evidence-based, medication treatments to patients with opioid use disorder in primary care, psychiatric care, substance use disorder treatment, and pain management settings.

Additional information on PCSS-MOUD from the FY 2023 Cooperative Agreement Notice of Funding Opportunity (NOFO) is available.

SAMHSA Point of Contact:

Training Support for Practitioners

PCSS-MOUD provides free training to increase healthcare providers’ knowledge and skills in the prevention, identification, and treatment of substance use disorder (SUD) with a focus OUD.

Learn more about PCSS-MOUD and register for classes.

Mentoring Support for Practitioners

Mentoring Support for Practitioners

The PCSS-MOUD mentoring program is a national network of trained clinicians with expertise in treating substance use disorders, co-occurring mental disorders, and pain management. There are three levels of mentoring support.

  • Discussion Forum moderated by addiction specialists, where health professionals can post questions and receive answers from clinical experts and other colleagues.
  • Ask a Clinical Question provides a simple and direct way for practitioners to receive answers related to substance use disorder, opioid use disorder, and other related topics via email.
  • One-on-One Mentoring provides individualized guidance via email, phone or in-person (if possible) on specific clinical questions.

SAMHSA funds the PCSS-MOUD to provide practitioner training in the evidence-based prevention and treatment of SUD and the trainings needed to apply for DEA registrations to prescribe Schedule II-V medications as directed in Section 1263 of the Consolidated Appropriations Act (PDF | 3.7 MB) of 2023 otherwise known as the Medication Access and Training Expansion (MATE) Act.

Harm Reduction: Compassionate Care for People who use Drugs - Podcast Series

PCSS-MOUD recently launched a new and exciting 8-part podcast series that delves into the critical importance of harm reduction. This series consists of 30-minute episodes hosted by distinguished members of the Association for Multidisciplinary Education and Research in Substance Use and Addiction (AMERSA).

Each episode will feature experts across different fields, providing a well-rounded perspective on the topic.

Register to be notified as new episodes become available and to listen to already aired podcasts.

Body 3

Payment Program for Rural Health Clinics

In June 2021, the Health Resources & Services Administration (HRSA) launched a Payment Program for Rural Health Clinics Buprenorphine-Trained Providers to improve access to medications for opioid use disorder treatment by paying for providers who are waivered to prescribe buprenorphine, a medication used to treat opioid use disorder.

Rural Health Clinics (RHCs) still have the opportunity to apply for a $3,000 payment on behalf of each provider who trained to obtain the waiver necessary to prescribe buprenorphine after January 1, 2019. Approximately $1.2 million in program funding remains available for RHCs and will be paid on a first-come, first-served basis until funds are exhausted.

Information and registration for free waiver training is available.

Please contact with any questions regarding this payment program.

Last Updated
Last Updated: 02/13/2024
Last Updated